Michael Henry Fiore sold $298k of HQY
EVP, CHIEF COMMERCIAL OFFICER at HEALTHEQUITY, INC.. 3,142 shares at an average of $95.00, traded May 29, 2026, filed Jun 2, 2026.
Score components
- +15RoleOfficer
- +14Trade size$298k at market
- 0Share of holdings soldSold 5.0% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002016116-26-000012, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 29, 2026 | SOpen-market sale Common Stock10b5-1 | -3,142 | $95.00 | $298k | 59,113 | Jun 2, 2026 |
Related signals
Other insiders at HEALTHEQUITY, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 7Weak | HEALTHEQUITY, INC. | Adrian T Dillon director | $798k 7,632 shares | -11% | |
| 7Weak | HEALTHEQUITY, INC. | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | $224k 2,354 shares | -4% | |
| 8Weak | HEALTHEQUITY, INC. | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | $235k 2,470 shares | -4% | |
| 30Weak | HEALTHEQUITY, INC. | Delano Ladd EVP, General Counsel | $675k 7,500 shares | -8% | |
| 12Weak | HEALTHEQUITY, INC. | Gayle Furgurson Wellborn director | $220k 2,439 shares | -11% | |
| 21Weak | HEALTHEQUITY, INC. | Delano Ladd EVP, General Counsel | $142k 1,500 shares | -2% | |
| 60Notable | HEALTHEQUITY, INC. | Elimelech Rosner EVP, CHIEF TECHNOLOGY OFFICER | $1.0M 10,959 shares | -19% | |
| 37Weak | HEALTHEQUITY, INC. | Gayle Furgurson Wellborn director | $425k 4,339 shares | -18% | |
| 6Weak | HEALTHEQUITY, INC. | Delano Ladd EVP, General Counsel | $157k 1,500 shares | -2% | |
| 14Weak | HEALTHEQUITY, INC. | Delano Ladd EVP, General Counsel | $138k 1,500 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.